Is consumer DNA testing actually a good business?

That was a natural question yesterday when yet another company joined the seemingly innumerable ranks of people selling at-home genetic tests.

The latest entrant is PerkinElmer, and it’s promising “actionable insights” to anyone willing to pay between $260 and $300 for its test. But how do you compete in such a crowded space? How much should actual doctors be involved? What happens to all of that patient data? And does any of this actually help people?

STAT’s Rebecca Robbins and Kate Sheridan dug into those very questions, and you can read the answers here.